Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$59.94
neg -1.11
-1.82%
Today's Range: 59.77 - 60.96 | TEVA Avg Daily Volume: 5,655,600
Last Update: 05/26/15 - 4:02 PM EDT
Volume: 4,051,389
YTD Performance: 6.16%
Open: $60.91
Previous Close: $61.05
52 Week Range: $47.36 - $68.75
Oustanding Shares: 848,000,000
Market Cap: 51,770,400,000
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 12 12 11
Moderate Buy 0 1 1 1
Hold 8 7 9 10
Moderate Sell 0 0 0 0
Strong Sell 1 0 0 0
Mean Rec. 2.05 1.75 1.86 1.95
Latest Dividend: 0.29
Latest Dividend Yield: 1.87%
Dividend Ex-Date: 05/15/15
Price Earnings Ratio: 40.97
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
40.97 19.00 27.04
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.96% 20.51% 55.82%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.20 0.11 0.03
Net Income 142.80 0.10 0.03
EPS 138.50 0.15 0.05
Earnings for TEVA:
EBITDA 6.00B
Revenue 20.27B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.31 $1.27 $5.21 $5.09
Number of Analysts 18 17 21 21
High Estimate $1.40 $1.35 $5.40 $5.46
Low Estimate $1.10 $1.16 $5.10 $4.24
Prior Year $1.23 $1.32 $5.07 $5.21
Growth Rate (Year over Year) 6.32% -3.83% 2.86% -2.47%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 21, 2015 | 6:49 PM EDT

Deals coming fast and furious in the best group in town.

By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Bryan Ashenberg

 | Apr 30, 2015 | 8:15 AM EDT

Merger rumors abound around salesforce.com.

By

David Peltier

 | Apr 29, 2015 | 4:42 PM EDT

Consumer, health care names lead market lower.

By

Bret Jensen

 | Apr 24, 2015 | 11:00 AM EDT

Watch for small biotechs partnering with bigger firms.

By

Antonia Oprita

 | Apr 22, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

David Peltier

 | Apr 21, 2015 | 4:49 PM EDT

U.S. stocks were mixed on Tuesday.

By

Jim Cramer

 | Apr 21, 2015 | 3:44 PM EDT

Biotech companies are saying, "I do."

By

David Katz

 | Apr 21, 2015 | 1:05 PM EDT

Teva bid highlights M&A action in health care sector.

By

David Katz

 | Apr 21, 2015 | 12:53 PM EDT

Teva bid highlights M&A action in health care sector.

The IRS said that identity thieves had accessed about 100,000 U.S. households' tax records...

Seems to be continuing rather strongly since April. Just sayin'...

The transports are breaking below the base support line of a large triangle top pattern on...

is this the beginning of the end for Jony Ive at AAPL? http://t.co/Ohw2qEL0w9...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.